CV Sciences, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CV Sciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- CV Sciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $3.00K, a 88.00% decline year-over-year.
- CV Sciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $12.00K, a 78.95% decline year-over-year.
- CV Sciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $161.00K, a 18.27% decline year-over-year.
- CV Sciences, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CV Sciences, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $175.00K, a 66.41% decline from fiscal 2019.
- CV Sciences, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $521.00K, a 1.36% increase from fiscal 2018.
- CV Sciences, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $514.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-04-04 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $175.00K 10-K · filed 2022-04-04 | |
| 2020-09-30 | $3.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $12.00K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $161.00K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $521.00K 10-K · filed 2021-03-19 | |
| 2019-09-30 | $25.00K 10-Q · filed 2020-11-06 | $449.68K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $57.00K 10-Q · filed 2020-11-06 | $660.68K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-03-31 | $197.00K 10-Q · filed 2020-11-06 | $711.68K derived: sum of 4 quarters · filed 2020-11-06 |
| 2018-12-31 | $170.68K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $514.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $236.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $108.00K 10-Q · filed 2019-11-06 |